Literature DB >> 31027857

Smoking and Total Hip Arthroplasty: Increased Inpatient Complications, Costs, and Length of Stay.

Eytan M Debbi1, Sean S Rajaee1, Andrew I Spitzer1, Guy D Paiement1.   

Abstract

BACKGROUND: Smoking is a potentially modifiable risk factor that may impact the overall outcomes of total hip arthroplasty (THA). In an era of bundled payments for THA, the purpose of this study was to evaluate, on a national level, the inpatient complications and additional costs of smokers undergoing THA.
METHODS: The Nationwide Inpatient Sample was used to identify all primary elective THAs performed in the United States in 2014. This cohort was further stratified by smoking status. Inpatient hospital characteristics, costs, and complications rates were assessed.
RESULTS: The Nationwide Inpatient Sample had 63,446 admissions recorded for primary THAs in 2014, corresponding to an estimated 317,230 cases nationwide. The smoking rate was 20.7%. Smokers were slightly yet significantly younger than nonsmokers (63.5 years vs 64.8 years; P < .0001). The smoking group had a significantly longer hospital stay and higher total hospital costs (both P < .0001). After using a multivariable logistic model adjusting for age, gender, and comorbidities, smokers were found to have a significantly higher odds ratio (OR [95% confidence interval {CI}]) for myocardial infarction (15.5 [5.0-47.5]), cardiac arrest (10.1 [2.2-47.6]), pneumonia (4.7 [2.4-9.1]), urinary tract infection (1.9 [1.4-2.7]), sepsis (13.1 [3.5-49.0]), acute renal failure (2.9 [2.2-3.7]), discharge to a skilled nursing facility (1.3 [1.2-1.4]), and mortality (11.7 [2.0-70.5]).
CONCLUSIONS: Smoking remains a highly prevalent and important risk factor for complications in elective primary THA in the United States. Patients who smoke have a significantly higher rate of complications and generate significantly higher postoperative inpatient costs. These findings are important for risk stratification, bundled payment considerations, as well as perioperative patient education and intervention.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  complications; cost; length of stay; smoking; total hip arthroplasty

Year:  2019        PMID: 31027857     DOI: 10.1016/j.arth.2019.03.059

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  5 in total

1.  Effect of Cigarette Smoking on Midterm Outcomes After Arthroscopic Surgery for Femoroacetabular Impingement Syndrome: A Propensity-Matched Controlled Study With Minimum 5-Year Follow-up.

Authors:  Andrew E Jimenez; Michael S Lee; Jade S Owens; David R Maldonado; Benjamin R Saks; Ajay C Lall; Benjamin G Domb
Journal:  Orthop J Sports Med       Date:  2022-05-10

2.  Comparison of Outcomes Between Nonsmokers and Patients Who Discontinued Smoking 1 Month Before Primary Hip Arthroscopy: A Propensity-Matched Study With Minimum 2-Year Follow-up.

Authors:  Michael S Lee; Andrew E Jimenez; Jade S Owens; Andrew J Curley; Olivia A Paraschos; David R Maldonado; Ajay C Lall; Benjamin G Domb
Journal:  Orthop J Sports Med       Date:  2022-06-08

3.  Effect of Cigarette Smoking on Outcomes in Patients Undergoing Primary Hip Arthroscopy and Labral Reconstruction: A Propensity-Matched Controlled Study With Minimum 2-Year Follow-up.

Authors:  Andrew E Jimenez; Michael S Lee; Tom George; Jade S Owens; David R Maldonado; Benjamin R Saks; Ajay C Lall; Benjamin G Domb
Journal:  Orthop J Sports Med       Date:  2022-02-24

4.  Nutritional Status According to the Short-Form Mini Nutritional Assessment (MNA-SF) and Clinical Characteristics as Predictors of Length of Stay, Mortality, and Readmissions Among Older Inpatients in China: A National Study.

Authors:  Hongpeng Liu; Jing Jiao; Minglei Zhu; Xianxiu Wen; Jingfen Jin; Hui Wang; Dongmei Lv; Shengxiu Zhao; Xiang Sun; Xinjuan Wu; Tao Xu
Journal:  Front Nutr       Date:  2022-01-25

5.  Outpatient vs. inpatient hip arthroplasty: a matched case-control study on a 90-day complication rate and 2-year patient-reported outcomes.

Authors:  Philip J Rosinsky; Sarah L Chen; Mitchell J Yelton; Ajay C Lall; David R Maldonado; Jacob Shapira; Mitchell B Meghpara; Benjamin G Domb
Journal:  J Orthop Surg Res       Date:  2020-08-31       Impact factor: 2.359

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.